Bayer Announces Phase III REVEAL Study with Investigational PET Radiotracer Iodine 124 Evuzamitide Presented as Late-Breaker at ESC 2026

Go back to Bayer Announces Phase III REVEAL Study with Investigational PET Radiotracer Iodine 124 Evuzamitide Presented as Late-Breaker at ESC 2026
Bay National Corporation (AMEX: BAYN) Delayed: 0.01 --0 (-0%)
Previous Close $0.01    52 Week High $0.04 
Open $61.11    52 Week Low $0.03 
Day High $0.01    P/E 0.00 
Day Low $0.01    EPS $-8.34 
Volume 358,028       

Bay National Corporation (AMEX: BAYN) Delayed: 0.01 --0 (-0%)
Previous Close $0.01    52 Week High $0.04 
Open $61.11    52 Week Low $0.03 
Day High $0.01    P/E 0.00 
Day Low $0.01    EPS $-8.34 
Volume 358,028       

Bayer Aktiengesellschaft American Depositary Shares (AMEX: BAYRY) Delayed: 12.24 +0.17 (1.41%)
Previous Close $12.07    52 Week High $135.54 
Open $12.13    52 Week Low $94.36 
Day High $12.34    P/E N/A 
Day Low $12.13    EPS $0.00 
Volume 296,432       

Bayer AG (AMEX: BAYZF) Delayed: 49.06 +1.06 (2.21%)
Previous Close $48.00    52 Week High $135.00 
Open $48.00    52 Week Low $94.95 
Day High $49.06    P/E N/A 
Day Low $49.06    EPS $0.00 
Volume 745